Last reviewed · How we verify
Single oral dose of cobicistat — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Single oral dose of cobicistat (Single oral dose of cobicistat) — Medicines for Malaria Venture.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Single oral dose of cobicistat TARGET | Single oral dose of cobicistat | Medicines for Malaria Venture | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Single oral dose of cobicistat CI watch — RSS
- Single oral dose of cobicistat CI watch — Atom
- Single oral dose of cobicistat CI watch — JSON
- Single oral dose of cobicistat alone — RSS
Cite this brief
Drug Landscape (2026). Single oral dose of cobicistat — Competitive Intelligence Brief. https://druglandscape.com/ci/single-oral-dose-of-cobicistat. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab